Page last updated: 2024-09-04

spiraprilat and Intraocular Pressure

spiraprilat has been researched along with Intraocular Pressure in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abrams, KL; Barnhill, MA; Brooks, DE; Frazier, D; Laratta, LJ1
Barnett, A; Baum, T; Pula, K; Tedesco, RP; Watkins, RW1
Cinotti, AA; Constad, WH; Fiore, P; Samson, C1
Ahn, HS; Barnett, A; Baum, T; Cedeno, K; Smith, EM; Watkins, RW; Yuen, PH1

Trials

1 trial(s) available for spiraprilat and Intraocular Pressure

ArticleYear
Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma.
    American journal of ophthalmology, 1988, Jun-15, Volume: 105, Issue:6

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Trials as Topic; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Phenylbutyrates; Pulse; Spiro Compounds; Time Factors; Timolol

1988

Other Studies

3 other study(ies) available for spiraprilat and Intraocular Pressure

ArticleYear
Angiotensin converting enzyme system in the normal canine eye: pharmacological and physiological aspects.
    Journal of ocular pharmacology, 1991,Spring, Volume: 7, Issue:1

    Topics: Administration, Topical; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Aqueous Humor; Dogs; Eye; Intraocular Pressure; Male; Ocular Physiological Phenomena; Peptidyl-Dipeptidase A; Phenylbutyrates; Random Allocation; Renin-Angiotensin System; Spiro Compounds

1991
Systemic effects resulting from topical ocular administration of SCH 33861, a novel ACE inhibitor ocular hypotensive agent.
    Journal of ocular pharmacology, 1988,Summer, Volume: 4, Issue:2

    Topics: Administration, Topical; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Heart Rate; Intraocular Pressure; Male; Phenylbutyrates; Rabbits; Spiro Compounds

1988
Topical ocular hypotensive effects of the novel angiotensin converting enzyme inhibitor SCH 33861 in conscious rabbits.
    Journal of ocular pharmacology, 1987,Winter, Volume: 3, Issue:4

    Topics: Administration, Topical; Angiotensin-Converting Enzyme Inhibitors; Animals; Chemical Phenomena; Chemistry; Consciousness; Intraocular Pressure; Male; Phenylbutyrates; Rabbits; Spiro Compounds; Time Factors; Timolol

1987